Hypertension and Pathogenic hAPP Independently Induce White Matter Astrocytosis and Cognitive Impairment in the Rat
Open Access
- 15 April 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 12, 82
Abstract
Hypertension is recognized as a risk factor for Alzheimer disease, but the causal link remains undetermined. Although astrocytes and microglia play an important role in maintaining the neurovascular unit, astrocytes and microglia have been understudied in comorbid models of hypertension and Alzheimer disease. In this study, male transgenic Fischer 344 rats (TgAPP21) overexpressing a pathogenic human amyloid precursor protein received 8 weeks of Angiotensin II infusion to increase blood pressure, and the rats were evaluated for astrocytosis, microgliosis, and cognitive function. A linear relationship between astrocytosis and blood pressure was observed in the corpus callosum and cingulum of wildtype rats, with hypertensive wildtype rats matching the elevated baseline astrocytosis seen in normotensive transgenic rats. In contrast, hypertensive transgenic rats did not demonstrate a further increase of astrocytosis, suggesting a deficient response. Angiotensin II infusion did not affect activation of microglia, which were elevated in the white matter and hippocampus of transgenic rats. Angiotensin II infusion did impair both wildtype and transgenic rats’ executive functions in the Morris Water Maze. These results present important implications for the interaction between hypertension and pathogenic human amyloid precursor protein expression, as Angiotensin II infusion produced cognitive impairments in both genotypes, but transgenic rats were additionally impaired in developing a normal astrocytic response to elevated blood pressure.Keywords
This publication has 61 references indexed in Scilit:
- Impact of Angiotensin Receptor Blockers on Alzheimer Disease Neuropathology in a Large Brain Autopsy SeriesArchives of Neurology, 2012
- Exogenous seeding of cerebral β‐amyloid deposition in βAPP‐transgenic ratsJournal of Neurochemistry, 2011
- Neural Mechanisms of Angiotensin II–Salt Hypertension: Implications for Therapies Targeting Neural Control of the Splanchnic CirculationCurrent Hypertension Reports, 2011
- The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertensionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Astrocytes: biology and pathologyActa Neuropathologica, 2009
- Role of Hypertension in Aggravating A Neuropathology of AD Type and Tau-Mediated Motor ImpairmentCardiovascular Psychiatry and Neurology, 2009
- Spatial reference and working memory across the lifespan of male Fischer 344 ratsNeurobiology of Aging, 2009
- Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trialThe Lancet Neurology, 2008
- Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidneyProceedings of the National Academy of Sciences, 2006
- Morris water maze: procedures for assessing spatial and related forms of learning and memoryNature Protocols, 2006